NEGOTIATIONS AND INFORMATION - APRIL 14-15, 2008
Negotiations and Information - Apr 14-15, 2008
Proteomic Approaches to Tumor Marker Discovery
Identification of Biomarkers for Ovarian Cancer. Current tumor markers for ovarian cancer still lack competent sense and specificity to be practical in large populations. High-throughput proteomic profiling and bioinformatics tools earmark for the fast display of a large sort of possibleness biomarkers in serum, plasma, or another embody fluids . Conclusions.—The compounded use of bioinformatics tools and proteomic profiling provides an effective move to concealment for possibleness tumor markers. Comparison of ECF profiles from patients with and without known ovarian cancer uncovered a commission of possibleness biomarkers for detection of ovarian cancer with discriminatory noesis unessential to that of CA125 . Additional studies are required to further validate these biomarkers. Source: Archives of Pathology and Laboratory Medicine: Vol. 126, No. 12, pp. 1518–1526.
Recovering from Surgery - Apr 10-13, 2008
Tags: boob cancer, mentality cancer, cancer, drugs for cancer, cancer doctor